2168-9709

Mental Health Clinician

American Association of Psychiatric Pharmacists (AAPP)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 530 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact530 DOIs
2

Add license metadata to 530 records

License metadata tells indexers and readers how each article may be reused.

High impact530 DOIs
3

Add abstracts to 279 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact279 DOIs

DOIs for this ISSN

Showing the top 5 of 930 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Benzodiazepine use, misuse, and abuse: A review (10.9740/mhc.2016.05.120)
ORCID License
111.39 168
2 Sexual dysfunction in selective serotonin reuptake inhibitor… (10.9740/mhc.2016.07.191)
ORCID License
101.67 107
3 Book Review: Diagnostic and statistical manual of mental dis… (10.9740/mhc.n163617)
Abstract References ORCID License
100.00 9
4 Dialectical behavior therapy as treatment for borderline per… (10.9740/mhc.2016.03.62)
ORCID License
94.04 75
5 Pharmacokinetic characteristics of antiepileptic drugs (AEDs… (10.9740/mhc.2015.01.008)
ORCID License
89.27 60
6 Brain-derived neurotrophic factor and schizophrenia (10.9740/mhc.2016.11.285)
ORCID License
84.95 49
7 A review of suicide risk assessment instruments and approach… (10.9740/mhc.2015.09.216)
ORCID License
82.17 43
8 Improving medication-related outcomes for patients with psyc… (10.9740/mhc.2015.01.001)
ORCID License
78.99 37
9 Management of antipsychotic-induced hyperprolactinemia (10.9740/mhc.2016.07.185)
ORCID License
76.57 33
10 Drug-induced cognitive impairment: Effect of cardiovascular… (10.9740/mhc.2016.07.201)
ORCID License
76.57 33
11 Antimicrobial-induced cognitive side effects (10.9740/mhc.2016.07.207)
ORCID License
73.12 28
12 A review of the clinical utility of serum clozapine and norc… (10.9740/mhc.2015.03.068)
ORCID License
72.36 27
13 Medical mimics: Differential diagnostic considerations for p… (10.9740/mhc.2016.11.289)
ORCID License
71.57 26
14 Review of antidepressants in the treatment of neuropathic pa… (10.9740/mhc.2015.05.123)
ORCID License
70.75 25
15 A review of significant pharmacokinetic drug interactions wi… (10.9740/mhc.2016.01.035)
ORCID License
70.75 25
16 Evaluation of the use of low-dose quetiapine and the risk of… (10.9740/mhc.2016.11.308)
ORCID License
69.01 23
17 A review of pharmacokinetic and pharmacodynamic interactions… (10.9740/mhc.2016.01.021)
ORCID License
68.09 22
18 Evaluation of QTc prolongation and dosage effect with citalo… (10.9740/mhc.2016.07.165)
ORCID License
66.11 20
19 Delta-9-tetrahydrocannabinol and cannabidiol: Separating the… (10.9740/mhc.2016.11.277)
ORCID License
66.11 20
20 Atypical antipsychotics: A review on the prevalence, monitor… (10.9740/mhc.2016.07.178)
ORCID License
65.05 19
21 Quantitative and economic analysis of clinical pharmacist in… (10.9740/mhc.2016.09.242)
ORCID License
65.05 19
22 Using Photovoice to explore patients' experiences with menta… (10.9740/mhc.2016.05.142)
ORCID License
63.94 18
23 Key differences between Venlafaxine XR and Desvenlafaxine: A… (10.9740/mhc.n186977)
ORCID License
63.94 18
24 A practical guide to tapering opioids (10.9740/mhc.2015.05.102)
ORCID License
62.76 17
25 Donepezil 23 mg: Is it more advantageous compared to the ori… (10.9740/mhc.n106739)
ORCID License
61.52 16
26 Antidepressants and suicidality: History, the black-box warn… (10.9740/mhc.2015.09.202)
ORCID License
57.31 13
27 Lowering the seizure threshold associated with antidepressan… (10.9740/mhc.n127568)
ORCID License
53.96 11
28 Knowledge, attitudes, and professional practices versus pers… (10.9740/mhc.n183649)
ORCID License
53.96 11
29 The impact of a pharmacist assisted clinic upon medication a… (10.9740/mhc.n133114)
Abstract ORCID License
52.42 4
30 Medication education task force providing valuable resources… (10.9740/mhc.n140747)
Abstract ORCID License
52.42 4
31 Toolbox: Psychotropic medications approved in children and a… (10.9740/mhc.n145473)
Abstract ORCID License
52.42 4
32 Review of pharmacologic treatment in cluster A personality d… (10.9740/mhc.2016.03.75)
ORCID License
52.07 10
33 Introduction to Parkinson disease (PD) and its complications (10.9740/mhc.2016.09.229)
ORCID License
52.07 10
34 Evaluation of clinical pharmacy services within the primary… (10.9740/mhc.2016.09.260)
ORCID License
52.07 10
35 Glycinergic signaling in the human nervous system: An overvi… (10.9740/mhc.2016.11.266)
ORCID License
52.07 10
36 Psychotropic medication abuse by inmates in correctional fac… (10.9740/mhc.n95631)
ORCID License
52.07 10
37 Suicide prevention in pharmaceutical education: Raising awar… (10.9740/mhc.2016.03.109)
ORCID License
50.00 9
38 Second-generation antipsychotic use in borderline personalit… (10.9740/mhc.2016.03.82)
ORCID License
50.00 9
39 Implementation and evaluation of a pharmacist-run mental hea… (10.9740/mhc.2016.05.159)
ORCID License
50.00 9
40 Academic detailing: Using clinical evidence to improve care (10.9740/mhc.n155291)
ORCID License
50.00 9
41 Management and prevention of agranulocytosis in patients rec… (10.9740/mhc.n166825)
ORCID License
50.00 9
42 Antidepressant medications: The FDA-approval process and the… (10.9740/mhc.n186950)
ORCID License
50.00 9
43 Impact of nighttime donepezil administration on sleep in the… (10.9740/mhc.n222761)
ORCID License
50.00 9
44 General pharmacokinetic/pharmacodynamic concepts of mood sta… (10.9740/mhc.2016.01.054)
ORCID License
47.71 8
45 Anti-NMDA receptor encephalitis: An emerging differential di… (10.9740/mhc.2016.11.297)
ORCID License
47.71 8
46 Book Review: Clinical handbook of psychotropic drugs, 19th r… (10.9740/mhc.n104535)
Abstract References ORCID License
47.71 2
47 CPNP Announcements (10.9740/mhc.n161423)
Abstract References ORCID License
47.71 2
48 Clinical psychiatric pharmacist involvement in an outpatient… (10.9740/mhc.n183353)
ORCID License
47.71 8
49 CPE monitor replaces ACPE paper statements of credit in 2012 (10.9740/mhc.n95634)
Abstract References ORCID License
47.71 2
50 Naloxone prescribing by psychiatric clinical pharmacists for… (10.9740/mhc.2015.01.046)
ORCID License
45.15 7